Alves João, Puga Marco, Fernandes Rodrigo, Pinton Anne, Miranda Ignacio, Kovoor Elias, Wattiez Arnaud
IRCAD (Research Institute Against Digestive Cancer), Strasbourg, France; Hospital da Luz, Lisboa, Portugal.
IRCAD (Research Institute Against Digestive Cancer), Strasbourg, France; Department of Gynecological Oncology, Universidad del Desarrollo Chile.
J Minim Invasive Gynecol. 2017 Mar-Apr;24(3):466-472. doi: 10.1016/j.jmig.2016.11.018. Epub 2017 Jan 12.
STUDY OBJECTIVE: To evaluate if laparoscopic treatment of ureteral endometriosis is feasible, safe, and effective and to determine if ureteral dilatation and/or the number of incisions increases complications.
An institutional review board-approved retrospective cohort study of consecutive patients who underwent surgery for deep infiltrating endometriosis involving the ureter with hydronephrosis (Canadian Task Force classification III).
A university hospital.
Of 658 patients who had surgery for deep infiltrating endometriosis between November 2004 and December 2013, 198 of the 658 patients had ureteral endometriosis and required ureterolysis, and 28 of the 198 patients were identified with ureteral dilatation and hydronephrosis associated with endometriosis.
Of these 28 cases, 15 ureterolyses, 12 reanastomoses, and 1 reimplantation were performed.
Medical, operative, and pathological data on the evolution of pain, urinary complaints, fertility, complications, and recurrences were collected from clinical records. Additionally, telephone interviews were performed for the follow-up of long-term outcomes. All 28 patients had concomitant surgical procedures because of endometriosis elsewhere in the pelvis or abdomen; 12 (42.9%) underwent surgery of the bowel, whereas 5 (17.9%) had bladder surgery. The evolution of pain after surgery showed a positive response (mean dysmenorrhea evaluation measured by the Numeric Pain Rating Scale from 0-10 preoperatively at the short-term follow-up and the long-term follow-up: 7.25-1.73 and 0.25, respectively). Three complications were noted in the group of 28 patients with ureterohydronephrosis; 1 required surgical reintervention. Logistic regression analyses found vaginal incision (odds ratio = 2.08; 95% CI 0.92-4.73), bladder incision (odds ratio = 8.77; 95% CI 3.25-23.63), number of incisions (odds ratio = 2.12; 95% CI 1.29-3.47), and number of previous surgeries (odds ratio = 1.26; 95% CI 0.93-1.71) as independent risk factors for complications in the group of 198 patients. Three patients underwent reoperation in the group of 28 patients: 1 for ureterovaginal fistula, 1 for persistent ureter dilatation and hydronephrosis, and 1 for persistent pain.
Laparoscopically assisted ureterolyses, ureteral reanastomoses, and ureteral reimplantation are feasible, safe, and effective treatments for ureteral endometriosis. Complete laparoscopic excision is possible with minimal complications, which seem to be associated with the number of incisions. Ureteral endometriosis should be suspected in all cases of deep infiltrating endometriosis.
评估腹腔镜治疗输尿管子宫内膜异位症是否可行、安全且有效,并确定输尿管扩张和/或切口数量是否会增加并发症。
一项经机构审查委员会批准的回顾性队列研究,研究对象为连续接受手术治疗的深部浸润性子宫内膜异位症累及输尿管并伴有肾积水的患者(加拿大工作组分类III级)。
一家大学医院。
在2004年11月至2013年12月期间接受深部浸润性子宫内膜异位症手术的658例患者中,198例患有输尿管子宫内膜异位症并需要进行输尿管松解术,其中28例患者被确定存在与子宫内膜异位症相关的输尿管扩张和肾积水。
在这28例病例中,进行了15例输尿管松解术、12例再吻合术和1例再植术。
从临床记录中收集有关疼痛演变、泌尿系统症状、生育能力、并发症和复发情况的医疗、手术和病理数据。此外,通过电话访谈对长期结局进行随访。所有28例患者均因盆腔或腹部其他部位的子宫内膜异位症而同时接受了手术;12例(42.9%)接受了肠道手术,而5例(17.9%)接受了膀胱手术。术后疼痛演变显示出积极的反应(术前通过数字疼痛评分量表测量的平均痛经评分为0 - 10分,短期随访和长期随访时分别为7.25 - 1.73分和0.25分)。在28例输尿管肾积水患者组中发现了3例并发症;1例需要再次手术干预。逻辑回归分析发现,阴道切口(比值比 = 2.08;95%可信区间0.92 - 4.73)、膀胱切口(比值比 = 8.77;95%可信区间3.25 - 23.63)、切口数量(比值比 = 2.12;95%可信区间1.29 - 3.47)和既往手术次数(比值比 = 1.26;95%可信区间0.93 - 1.71)是198例患者组并发症的独立危险因素。28例患者组中有3例接受了再次手术:1例因输尿管阴道瘘,1例因持续性输尿管扩张和肾积水,1例因持续性疼痛。
腹腔镜辅助输尿管松解术、输尿管再吻合术和输尿管再植术是治疗输尿管子宫内膜异位症可行、安全且有效的方法。完全腹腔镜切除是可行的,并发症最少,并发症似乎与切口数量有关。在所有深部浸润性子宫内膜异位症病例中均应怀疑输尿管子宫内膜异位症。